What's new in hypophosphataemic rickets?

European Journal of Pediatrics

Volumn 167, Issue 5, 2008, Pages 493-499

  Pettifor, John M ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

FGF 23; Hypophosphataemic rickets; MEPE; PHEX; Phosphatonins; Polyostotic fibrous dysplasia; Renal tubular reabsorption of phosphate; Tumour induced rickets

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; HORMONE; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; OXYGENASE; PHOSPHATE; PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; PHOSPHATONIN; UNCLASSIFIED DRUG;

ALBRIGHT SYNDROME; BONE MINERALIZATION; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVITY; GENE MUTATION; HOMEOSTASIS; HUMAN; HYPOPHOSPHATEMIC RICKETS; KIDNEY TUBULE ABSORPTION; ONCOGENIC OSTEOMALACIA; PHOSPHATE METABOLISM; PRIORITY JOURNAL; REVIEW;

ANIMALS; EXTRACELLULAR MATRIX PROTEINS; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; PHEX PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; PHOSPHOPROTEINS; PHOSPHORUS; RNA, MESSENGER; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41049103994     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-007-0662-1     Document Type: Review

References (28)

1. Alon U, Hellerstein S (1994) Assessment and interpretation of the tubular threshold for phosphate in infants and children. Pediatr Nephrol 8:250-251
2. Cho HY, Lee BH, Choi HJ, Ha IS, Choi Y, Cheong HI (2007) Renal manifestations of Dent disease and Lowe syndrome. Pediatr Nephrol [Epub ahead of print]
3. Econs MJ, McEnery PT (1997) Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab 82:674-681
4. Eyskens B, Proesmans W, Van Damme B, Lateur L, Bouillon R, Hoogmartens M (1995) Tumour-induced rickets: a case report and review of the literature. Eur J Pediatr 154:462-468
5. Ferrari SL, Bonjour JP, Rizzoli R (2005) Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90:1519-1524
6. Garabedian M (2007) Regulation of phosphate homeostasis in infants, children, and adolescents, and the role of phosphatonins in this process. Curr Opin Pediatr 19:488-491
7. Hesse E, Moessinger E, Rosenthal H, Laenger F, Brabant G, Petrich T, Gratz KF, Bastian L (2007) Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography. J Bone Miner Res 22:158-162
8. Hoffman WH, Jüppner HW, Deyoung BR, O'Dorisio MS, Given KS (2005) Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome. Am J Med Genet A 134:233-236
9. Imel EA, Hui SL, Econs MJ (2007) FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J Bone Miner Res 22:520-526
10. Ito N, Fukumoto S, Takeuchi Y, Takeda S, Suzuki H, Yamashita T, Fujita T (2007) Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans. J Bone Miner Metab 25:419-422
11. Kronenberg HM (2002) NPT2a-the key to phosphate homeostasis. N Engl J Med 347:1022-1024
12. Larsson T, Nisbeth U, Ljunggren O, Jüppner H, Jonsson KB (2003) Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64:2272-2279
13. Liu S, Brown TA, Zhou J, Xiao ZS, Awad H, Guilak F, Quarles LD (2005) Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia. J Am Soc Nephrol 16:1645-1653
14. Lorenz-Depiereux B, Benet-Pages A, Eckstein G, Tenenbaum-Rakover Y, Wagenstaller J, Tiosano D, Gershoni-Baruch R, Albers N, Lichtner P, Schnabel D, Hochberg Z, Strom TM (2006) Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet 78:193-201
15. Moran M, Paul A (2002) Octreotide scanning in the detection of a mesenchymal tumour in the pubic symphysis causing hypophosphataemic osteomalacia. Int Orthop 26:61-62
16. Nesbitt T, Coffman TM, Griffiths R, Drezner MK (1992) Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect. J Clin Invest 89:1453-1459
17. Qin C, D'Souza R, Feng JQ (2007) Dentin matrix protein 1 (DMP1): new and important roles for biomineralization and phosphate homeostasis. J Dent Res 86:1134-1141
18. Quarles LD (2003) FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 285:E1-E9
19. Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P (2003) FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112:683-692
20. Rowe PSN, Garrett IR, Schwarz PM, Carnes DL, Lafer EM, Mundy GR, Gutierrez GE (2005) Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP). Bone 36:33-46
21. Silve C (2006) DMP1 and phosphate metabolism-matrix proteins go systemic. BoneKEy-Osteovision 3:30-35
22. Skinner R (2003) Chronic ifosfamide nephrotoxicity in children. Med Pediatr Oncol 41:190-197
23. The HYP Consortium (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nature Genet 11:130-136
24. Walton RJ, Bijvoet OL (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309-310
25. Weber TJ, Liu S, Indridason OS, Quarles LD (2003) Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18:1227-1234
26. White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ (2001) Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60:2079-2086
27. White KE, Larsson TE, Econs MJ (2006) The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23. Endocr Rev 27:221-241
28. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87:4957-4960